Library - Page 10 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Features of patients with traumatic brain injury

Authors:
M.L. CHUKHLOVINA¹, A.A. CHUKHLOVIN²

¹Almazov National Medical Research Center of the Russian Ministry of Health, Saint Petersburg, Russia;
²Russian Neurosurgical Research Institute named after prof. A.L. Polenov — branch of the Almazov National Medical Research Center of the Russian Ministry of Health, Saint Petersburg, Russia

Vascular inflammation based on the development of atherotrombotic stroke

Authors:
A.V. ROMANENKO, I.P. AMELINA, E.Yu. SOLOVYEVA

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Features of stress response in elderly men and women with chronic cerebral ischemia

Authors:
SLYUSAR T.A., ABRAMENKO Y.V., RUBINA S.S., MAYOROV R.V., SLYUSAR I.N.

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver

Clinical efficacy of antioxidant therapy with Mexidol FORTE in 250 patients with chronic cerebral venous insufficiency

Authors:
E.I. CHUKANOVA, A.S. CHUKANOVA, H.I. MAMAEVA

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The influence of Mexidol on the quality of life and the functional status of patients with chronic ischemia of the brain and chronic heart failure with a low emission fraction

Authors:
V.V. TOLKACHEVA¹, E.R. KAZAKHMEDOV¹, J.D. KOBALAVA¹, S.A. GALOCHKIN¹, A.V. SHCHULKIN²

¹Peoples' Friendship University of Russia, Moscow, Russia;
²Ryazan State Medical University named after Academician I.P. Pavlov of the Ministry of Health of the Russian Federation, Ryazan, Russia

Efficacy and safety of ethylmethylhydroxypyridine succinate in sequential therapy in patients with chronic cerebral ischemia

Author:
V.V. BURDAKOV, D.V. KRASNYKH

Federal State Budgetary Educational Institution of Higher Education "Orenburg State Medical University" of the Ministry of Health of the Russian Federation, Orenburg, Russia

The effectiveness and safety of the use of ethylmethylhydroxypyridine of succinate in patients with acute ischemic stroke

Authors:
M.V. ZHURAVLEVA^1,2, I.A. SHCHUKIN³, M.S. FIDLER³, A.B. PROKOFIEV^1,2, S.Yu. SEREBROVA^1,2, N.S. VASYUKOVA⁴, E.Yu. DEMCHENKOVA¹, V.V. ARKHIPOV¹

The effectiveness and safety of Mexidol in patients of different age groups in the acute and early recovery periods of the hemisphere ischemic stroke (the results of subanarized a randomized double blind multicenter placebo-controlled in parallel groups of the study of epic)

L.V. STAKHOVSKAYA¹, E.A. MKHITARYAN², O.N. TKACHEV^1,2, T.M. OSTROUMOVA³, O.D. OSTROUMOVA^3.4

¹N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
²Russian Gerontology Research and Clinical Center of N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
³I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
⁴Russian Medical Academy of Continuous Professional Education, Moscow, Russia

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2020, Vol. 120, No. 8, Issue 2

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in patients with cerebrovascular pathology against the background of diabetes and metabolic syndrome

Authors:
E.V. EKUSHEVA^1,2, E.V. BIRYUKOVA³

¹Federal State Budgetary Institution "Academy of Postgraduate Education "Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency", Moscow, Russia;
²Belgorod State National Research University, Belgorod, Russia;
³A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation, Moscow, Russia

Efficacy and safety of Mexidol FORTE 250 in sequential therapy of patients with chronic cerebral ischemia

Authors:
N.G. KATAEVA¹, T.A. ZAMOSHCHINA^1,2, M.V. SVETLIK^1,2

¹Federal State Budgetary Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation, Tomsk, Russia;
²Federal State Autonomous Educational Institution of Higher Education “National Research Tomsk State University”, Tomsk, Russia

Study of the effectiveness and safety of the drug Mexol Fort 250 as part of consecutive therapy in patients with a hemisphere ischemic stroke in acute and early recovery periods

Authors:
M.A. Loskutnikov, M.A. Domashenko, T.M. Vakin, I.A. Trushina, V.I. Konstantinov, O.S. Proskuryakova, E.P. Shchukina

Elderly patient with cerebrovascular pathology: features of examination and management

Authors:
E.V. EKUSHEVA, E.A. MKHITARYAN

The role of oxidant stress in the development of vascular cognitive disorders

Author:
A.N. BOGOLEPOVA

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;

FSBI "Federal Center for Brain and Neurotechnology" FMBA of Russia, Moscow, Russia

Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia

Authors:
M.V. ZHURAVLEVA^1,2, A.B. PROKOFIEV^1,2, S.Yu. SEREBROVA^1,2, N.S. VASYUKOVA³, E.Yu. DEMCHENKOVA¹, V.V. ARKHIPOV¹

¹Federal State Budgetary Institution "Scientific Center for Expertise of Medical Products" of the Ministry of Health of the Russian Federation, Moscow, Russia;
²Federal State Autonomous Educational Institution of Higher Education "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia;
³Federal Scientific Center - All-Russian Research Institute of Experimental Veterinary Medicine named after K.I. Skryabin and Ya.R. Kovalenko of the Russian Academy of Sciences, Moscow, Russia

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in the restoration treatment of patients who have undergone ischemic stroke

Authors:
M.V. ZHURAVLEVA^1,2, A.B. PROKOFIEV^1,2, V.V. ARKHIPOV¹, S.Yu. SEREBROVA^1,2, G.I. GORODETSKAYA^1,2, O.A. DEMIDOVA¹

The effectiveness and safety of the drug Mexidol Fort 250 in the framework of prolonged consistent therapy in patients with ischemic stroke in a carotide pool

Authors:

I.A. STRELNIKOVA¹, A.A. SVETKINA^1,2, O.V. ANDROFAGINA¹

¹State Budgetary Healthcare Institution "Samara Regional Clinical Hospital named after V.D. Seredavin" of the Ministry of Health of the Samara Region, Samara, Russia;
²Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Health of the Russian Federation, Samara, Russia

« 1 … 8 9 10 11 12 … 14 »